References
- Citrome L. Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability. Expert Opin Drug Metab Toxicol. 2012;8:873–888.
- Levine M, Lovecchio F, Tafoya P, et al. Paliperidone overdose with delayed onset of toxicity. Ann Emerg Med. 2011;58:80–82.
- Helldin L, Peuskens J, Vauth R, et al. Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophrenia. Ther Adv Psychopharmacol. 2015;5:194–207.
- Tsay M, Klein-Schwartz W, Anderson B. Toxicity and clinical outcomes of paliperidone exposures reported to U.S. Poison Centers. Clin Toxicol (Phila). 2014;52:207–213.
- Chang JP, Huang CC, Su KP, et al. Paliperidone overdose in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:418.